Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine (2016)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1002/jcph.758
- Subjects: CÉLULAS-TRONCO; FARMACOCINÉTICA
- Keywords: PHARMACOKINETICS; BUSULFAN; FLUDARABINE; ORAL TEST DOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 56, n. 12, p. 1555-1562, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 13 fev. 2026. -
APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758 -
NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1002/jcph.758 -
Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1002/jcph.758 - Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis
- Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
- Influence of type-2 diabetes mellitus on the stereoselective kinetic disposition of fluvastatin
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
- Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectometry
Informações sobre o DOI: 10.1002/jcph.758 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
